When Connecticut’s nearly 34,000 medical cannabis patients purchase their medicine, they do so with the trust that it is safe, pure, and held to the highest legal standards. That trust is the very foundation of our state’s regulated cannabis program. But a recent, quietly issued interpretation from the Department of Consumer Protection threatens to erode that foundation, raising serious questions about whether consumer safety is being compromised.

The issue stems from a March 6, 2025, email from the DCP’s General Counsel, which stated that cannabis is not considered “adulterated” even if it has been treated with radiation. This technique, often called remediation, is used to kill mold, yeast, and bacteria on cannabis that may have failed initial testing. In essence, it’s a way to clean

See Full Page